Journal of Medical Virology,
Journal Year:
2023,
Volume and Issue:
95(6)
Published: June 1, 2023
Abstract
Recently
emerging
severe
acute
respiratory
syndrome
coronavirus
2
(SARS‐CoV‐2)
Omicron
variants
are
generally
less
pathogenic
than
previous
strains.
However,
elucidating
the
molecular
basis
for
pulmonary
immune
response
alterations
is
challenging
owing
to
virus's
heterogeneous
distribution
within
complex
tissue
structure.
Here,
we
revealed
spatial
transcriptomic
profiles
of
microstructures
at
SARS‐CoV‐2
infection
site
in
nine
cynomolgus
macaques
upon
inoculation
with
Delta
and
variants.
Delta‐
Omicron‐infected
lungs
had
upregulation
genes
involved
inflammation,
cytokine
response,
complement,
cell
damage,
proliferation,
differentiation
pathways.
Depending
on
(alveoli,
bronchioles,
blood
vessels),
there
were
differences
types
significantly
upregulated
each
pathway.
Notably,
a
limited
number
damage
differentially
expressed
between
bronchioles
Omicron‐infection
groups.
These
results
indicated
that
despite
significant
antigenic
shift
SARS‐CoV‐2,
host
mechanisms
induced
by
relatively
consistent,
transcriptional
observed
only
large
airways.
This
study
may
aid
understanding
pathogenesis
developing
clinical
strategy
addressing
dysregulation
identifying
potential
biomarkers
during
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Nov. 3, 2023
Abstract
Passively
administered
monoclonal
antibodies
(mAbs)
given
before
or
after
viral
infection
can
prevent
blunt
disease.
Here,
we
examine
the
efficacy
of
aerosol
mAb
delivery
to
and
disease
in
rhesus
macaques
inoculated
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
Delta
variant
via
intranasal
intratracheal
routes.
SARS-CoV-2
human
mAbs
a
directed
syncytial
virus
(RSV)
are
nebulized
delivered
using
positive
airflow
facemask
sedated
pre-
post-infection.
Nebulized
detectable
nasal,
oropharyngeal,
bronchoalveolar
lavage
(BAL)
samples.
treatment
significantly
reduces
levels
RNA
infectious
upper
lower
tracts
relative
controls.
Reductions
lung
BAL
correspond
reduced
inflammatory
cytokines
pathology.
Aerosolized
antibody
therapy
for
could
be
effective
reducing
burden
limiting
severity.
One Health Advances,
Journal Year:
2024,
Volume and Issue:
2(1)
Published: Jan. 11, 2024
Abstract
Avian-origin
H3N2
canine
influenza
virus
(CIV)
is
one
of
the
most
prevalent
subtypes
in
dogs
worldwide.
Previous
studies
have
shown
that
during
evolution
CIV
dogs,
its
adaptability
mammals
increased
gradually,
suggesting
can
serve
as
a
potential
intermediate
host
for
cross-species
transmission
avian
virus.
In
this
study,
we
report
results
from
surveillance
and
characterization
CIVs
isolated
animal
hospitals
kennels
2021
China.
We
characterized
CIVs’
genetic
antigenic
variation,
receptor-binding
specificity,
virulence
mice.
The
hemagglutinin
(HA)
phylogenetic
result
showed
these
belonged
to
Clade
5.1,
clade
formed
after
2019.
Compared
2016–2019
strains
China,
had
similar
antigenicity
specificity.
pathogenicity
mice
was
significantly
reduced
infection
with
two
strains,
but
replication
capacity
similar,
virus-host
balance
might
been
established.
This
emphasizes
importance
close
monitoring
prevent
emergence
novel
viruses
public
health
threats.
Stem Cell Reports,
Journal Year:
2024,
Volume and Issue:
19(4), P. 545 - 561
Published: March 28, 2024
The
emergence
of
severe
acute
respiratory
syndrome-coronavirus-2
(SARS-CoV-2)
variants
necessitated
a
rapid
evaluation
system
for
their
pathogenesis.
Lung
epithelial
cells
are
entry
points;
however,
in
addition
to
limited
source,
the
culture
human
alveolar
is
especially
complicated.
Induced
pluripotent
stem
(iPSCs)
an
alternative
source
primary
cells.
Here,
we
report
model
distinguishing
SARS-CoV-2
at
high
resolution,
using
separately
induced
iPSC-derived
and
airway
micro-patterned
plates.
position-specific
signals
apical-out
type
2
multiciliated
periphery
center
colonies,
respectively.
infection
studies
each
lineage
enabled
profiling
pathogenesis
variants:
efficiency,
tropism
lineages,
responses.
These
results
indicate
that
this
suitable
predicting
emergent
variants.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 21, 2025
We
aimed
to
investigate
changes
in
the
ocular
disease
spectrum
during
coronavirus
disease-2019
(COVID-19)
pandemic
late
2022
Hubei
Province.
This
retrospective
observational
study
was
conducted
two
parts.
The
first
part
involved
collecting
COVID-19-related
information
from
residents
of
Province
through
an
online
questionnaire
survey.
second
extracting
electronic
medical
records
ophthalmology
outpatient
departments
at
hospitals
and
epidemic
prevention
control
periods,
analyzing
diseases.
In
part,
31.65%
patients
with
systemic
symptoms
COVID-19
experienced
discomfort.
most
common
were
eye
fatigue,
pain
dry
eye.
76.5%
who
visited
ophthalmic
clinic
had
period.
proportion
cornea/keratitis,
glaucoma/acute
angle-closure
glaucoma
(AACG)
vitreoretinal
disease/retinal
vein
obstruction
(RVO)/acute
macular
neuroretinalpathy
(AMN)
increased
markedly
Additionally,
number
under
18
years
over
60
decreased
significantly
compared
same
age
groups
pre-
&
post-pandemic.
has
led
certain
diseases,
which
warrants
attention
ophthalmologists.
EBioMedicine,
Journal Year:
2023,
Volume and Issue:
99, P. 104916 - 104916
Published: Dec. 15, 2023
Earlier
Omicron
subvariants
including
BA.1,
BA.2,
and
BA.5
emerged
in
waves,
with
a
subvariant
replacing
the
previous
one
every
few
months.
More
recently,
post-BA.2/5
have
acquired
convergent
substitutions
spike
that
facilitated
their
escape
from
humoral
immunity
gained
ACE2
binding
capacity.
However,
intrinsic
pathogenicity
replication
fitness
of
evaluated
are
not
fully
understood.
Virology Journal,
Journal Year:
2023,
Volume and Issue:
20(1)
Published: May 29, 2023
Abstract
Background
The
pathogenicity
and
virulence
of
the
Omicron
strain
have
weakened
significantly
pathogenesis
variants.
Accumulating
data
indicated
accessory
proteins
play
crucial
roles
in
host
immune
evasion
virus
SARS-CoV-2.
Therefore,
impact
simultaneous
deletion
protein
ORF7a,
ORF7b
ORF8
on
clinical
characteristics
specific
immunity
breakthrough
infected
patients
(BIPs)
need
to
be
verified.
Methods
Herein,
plasma
cytokines
were
identified
using
a
commercial
Multi-cytokine
detection
kit.
Enzyme-linked
immunosorbent
assay
pseudovirus
neutralization
assays
utilized
determine
titers
SARS-CoV-2
binding
antibodies
neutralizing
antibodies,
respectively.
In
addition,
an
enzyme-linked
immunospot
was
used
quantify
T
cells
memory
B
cells.
Results
A
local
COVID-19
outbreak
caused
by
BA.2
variant,
which
featured
871
base
pairs
(∆871
BA.2),
resulting
removal
ORF7b,
ORF8.
We
found
that
hospitalized
with
∆871
had
shorter
hospital
stays
than
those
wild-type
(WT)
BA.2.
Plasma
cytokine
levels
both
WT
within
normal
range
reference,
there
no
notable
difference
ancestor
or
Omicron-specific
IgG
antibody
titers,
effector
cells,
frequencies
between
adult
patients.
However,
adolescents
higher
adults.
Conclusions
facilitates
rapid
clearance
without
impacting
affecting
humoral
cellular
Omicron-infected
individuals.
There
is
tremendous
heterogeneity
in
the
severity
of
COVID-19
disease
human
population,
and
mechanisms
governing
development
severe
remain
incompletely
understood.
The
emergence
SARS-CoV-2
variants
concern
(VOC)
Delta
(B.1.617.2)
Omicron
(B.1.1.529)
further
compounded
this
heterogeneity.
Virus
replication
host
cell
damage
distal
lung
often
associated
with
clinical
disease,
making
an
important
site
to
consider
when
evaluating
pathogenicity
VOCs.
Using
organoids
(hLOs)
derived
from
multiple
donors,
we
compared
fitness
VOC
Omicron,
along
ancestral
clade
B
variant
D614G,
evaluated
donor-dependent
differences
susceptibility
infection.
We
observed
substantial
attenuation
hLOs
demonstrated
enhanced
D614G
one
donor.
Transcriptomic
analysis
revealed
that
increased
infection
these
was
reduced
tonic
interferon
signaling
activity
at
baseline.
show
can
be
used
model
pathogenesis
humans,
propose
variability
set
point
may
impact
VOCs
subsequent
progression.
Virulence,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Feb. 16, 2024
Animal
models
that
can
replicate
clinical
and
pathologic
features
of
severe
human
coronavirus
infections
have
been
instrumental
in
the
development
novel
vaccines
therapeutics.
The
goal
this
review
is
to
summarize
our
current
understanding
pathogenesis
disease
2019
(COVID-19)
be
observed
several
currently
available
animal
models.
Knowledge
gained
from
studying
these
SARS-CoV-2
infection
help
inform
appropriate
model
selection
for
modelling
as
well
vaccine
therapeutic
developments.